Calidi Biotherapeutics Files Q1 2025 10-Q
Ticker: CLDWW · Form: 10-Q · Filed: May 14, 2025 · CIK: 1855485
| Field | Detail |
|---|---|
| Company | Calidi Biotherapeutics, Inc. (CLDWW) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotechnology, financials
Related Tickers: CLDI
TL;DR
Calidi Bio (CLDI) filed Q1 2025 10-Q. Financials updated.
AI Summary
Calidi Biotherapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as First Light Acquisition Group, Inc., is involved in biological products. Key financial data and reporting periods are detailed within the filing.
Why It Matters
This filing provides investors with an update on Calidi Biotherapeutics' financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a biotechnology company, Calidi Biotherapeutics is subject to inherent risks associated with drug development, regulatory approvals, and market acceptance.
Key Numbers
- Q1 2025 — Reporting Period (The 10-Q covers the first quarter of 2025.)
- 20250331 — As of Date (The financial information is reported as of March 31, 2025.)
Key Players & Entities
- Calidi Biotherapeutics, Inc. (company) — Filer of the 10-Q
- First Light Acquisition Group, Inc. (company) — Former name of Calidi Biotherapeutics, Inc.
- 20250331 (date) — Period of report for the 10-Q
- 20250514 (date) — Filing date of the 10-Q
- 001-40789 (dollar_amount) — SEC File Number
FAQ
What is the primary business of Calidi Biotherapeutics, Inc.?
Calidi Biotherapeutics, Inc. is involved in the business of biological products, specifically classified under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)'.
When was the 10-Q filing submitted?
The 10-Q filing was submitted on May 14, 2025.
What is the fiscal year end for Calidi Biotherapeutics, Inc.?
The fiscal year end for Calidi Biotherapeutics, Inc. is December 31.
What was the company formerly known as?
The company was formerly known as First Light Acquisition Group, Inc., with a name change date of April 6, 2021.
What is the SEC file number for Calidi Biotherapeutics, Inc.?
The SEC file number for Calidi Biotherapeutics, Inc. is 001-40789.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Calidi Biotherapeutics, Inc. (CLDWW).